(Q36512651)

English

Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults

scientific article published on April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1 reference

based on heuristic

inferred from title

author name string

Laurence Y Katz

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Anita L Kozyrskyj

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Heather J Prior

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Murray W Enns

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Brian J Cox

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Jitender Sareen

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

0 references

publication date

1 April 2008

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Canadian Medical Association Journal

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

178

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1005-1011

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276558

30 September 2017

Pediatric primary care providers and adolescent depression: a qualitative study of barriers to treatment and the effect of the black box warning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276558

30 September 2017

Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276558

30 September 2017

The effect of the withdrawal of rofecoxib on prescribing patterns of COX-2 inhibitors in Scotland

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276558

30 September 2017

Decrease in antibiotic use among children in the 1990s: not all antibiotics, not all children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276558

30 September 2017

Modern statistical techniques for the analysis of longitudinal data in biomedical research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276558

30 September 2017

A research registry: uses, development, and accuracy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276558

30 September 2017

Estimating the burden of disease. Comparing administrative data and self-reports

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276558

30 September 2017

Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276558

28 June 2018

Effects of Food and Drug Administration warnings on antidepressant use in a national sample

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276558

21 September 2018

Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276558

21 September 2018

The FDA pediatric advisories and changes in diagnosis and treatment of pediatric depression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276558

21 September 2018

The effect of antidepressant warnings on prescribing trends in Ontario, Canada.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276558

21 September 2018

Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276558

21 September 2018

Suicidality in pediatric patients treated with antidepressant drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276558

21 September 2018

Do antidepressants precipitate youth suicide?: a nationwide pharmacoepidemiological study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276558

21 September 2018

Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14,857 suicides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276558

21 September 2018

Paroxetine, other antidepressants, and youth suicide in New York City: 1993 through 1998.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276558

21 September 2018

Effect of regulatory warnings on antidepressant prescribing for children and adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The revised warning for antidepressants and suicidality: unveiling the black box of statistical analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of an electronic, population-based prescription database

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1503/CMAJ.071265

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36512651&oldid=1636493658"